Trials
Search / Trial NCT05640895

Intravitreal Injection Site and Perceived Pain

Launched by THE UNIVERSITY OF TEXAS MEDICAL BRANCH, GALVESTON · Dec 6, 2022

Apply for Trial

Trial Information

Current as of January 14, 2025

Recruiting

Keywords

Intravitreal Injection Retinal Diseases Age Related Macular Degeneration Diabetic Retinopathy Retinal Vein Occlusion Limbus Quadrants (Regions) Of The Eye Injection Site Pseudophakic/Aphakic Eyes Phakic Eyes Pars Plana Ciliary Body Vitrectomy Crystalline Lens Retina Bevacizumab Ranibizumab Aflibercept Diabetic Macular Edema Anti Vegf (Vascular Endothelial Growth Factor) Vabysmo

ClinConnect Summary

This clinical trial is looking into how much pain people feel during a specific eye treatment called intravitreal injection, which is used to treat conditions like diabetic macular edema, age-related macular degeneration, and retinal vein occlusion. The study aims to see if the pain experienced is affected by how far the injection site is from a part of the eye called the limbus. They are currently recruiting participants aged 18 to 100 who have already been diagnosed with one of these eye conditions and require at least two injections.

If you or a family member are considering participating, you should know that you cannot be part of the study if this is your first injection or if you are under 18. Participants will receive their injections as usual, and the study will help researchers understand pain levels better, which may lead to improved treatment in the future. Your involvement could contribute to important findings in eye care.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Age 18 -100 years
  • • Diagnosis of diabetic macular edema, age related macular degeneration, or retinal vein occlusion
  • • Treated with bevacizumab, ranibizumab, aflibercept
  • • The need for at least two intravitreal injections
  • • Pseudophakia
  • Exclusion Criteria:
  • • Texas Department of Corrections medical records
  • • Under 18 years-of-age
  • • First intravitreal injection experience of patient

Trial Officials

Touka K Banaee, MD

Principal Investigator

University of Texas

About The University Of Texas Medical Branch, Galveston

The University of Texas Medical Branch (UTMB) in Galveston is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. As a prominent sponsor of clinical trials, UTMB leverages its extensive resources, multidisciplinary expertise, and commitment to excellence to facilitate groundbreaking studies that address critical health challenges. With a focus on translating scientific discoveries into effective therapies, UTMB fosters collaboration among researchers, clinicians, and participants to enhance patient outcomes and contribute to the overall advancement of medical knowledge.

Locations

Galveston, Texas, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials